NICE guideline focuses on care for patients with cancer of unknown primary

Source: Cancer Research UK

Follow this link for fulltext

Date of publication: July, 2010

Publication type: News Item

In a nutshell: NICE has recommended a raft of measures to tackle the current inequality in care received by patients with so-called cancer of unknown primary (CUP) compared with those being treated for a site-specific cancer.

Length of publication: 1 web page

MPs warn NICE over cancer drug ‘inequities’

Source: Health Service Journal, 2009

Follow this link for News Item

Date of publication: May 2009

Publication type: News Item

In a nutshell: MPs have attacked as “inequitable and inefficient” the decision by the National Institute for Health and Clinical Excellence to allow less cost efficient drugs to be given to people at the end of their lives.

Length of publication:1 web page

Public funding of new cancer drugs: Is NICE getting nastier?

Source: European Journal of Cancer – January 2009 

For abstract link here 

 

Year of publication: 2009

 

Publication type: Journal Article

 

In a nutshell: This journal article attempts to answer the question: is NICE rejecting a higher proportion of cancer drugs and have the reasons for restricting technologies changed

  

Length of publication: 1 page abstract

  

Some important notes: contact you local NHS Library for access to the full text

  

Further dissemination: If you think anyone would benefit from receiving this posting or from subscribing to this blog, please email them the link to this blog and suggest they sign up to the blog’s email newsletter to stay up to date with new content.